JAIPUR: Glenmark Foundation, the Corporate Social Responsibility (CSR) arm of Glenmark Pharmaceuticals has announced the launch of its flagship programme, ‘Project Kavach’ – ‘Healthy Children, Healthier World’ in the state of Rajasthan. The campaign addresses the important issue of high Infant and Child Mortality by focusing on 3 key agendas – reducing malnutrition, increasing immunization and promoting good hygiene practices among pregnant mothers and caregivers.
Glenmark Foundation has announced that will adopt over 150 villages near Jaipur in the initial phase of ‘Project Kavach’. For expanding its reach, the Foundation has also tied with a local NGO called SIDART (Society for Integrated Developmental Activities Research and Training).
The launch of Glenmark’s – ‘Project Kavach’ in Jaipur recently was attended by prominent officials from the Government of Rajasthan; including Hon’ble Health Minister – Mr. Aimadudddin Ahmad Khan.
“Despite improvements in health care facilities in recent past; children below the age of five constitute the most vulnerable group in India with lives being lost due to malnutrition, lack of medicines and vaccination, inadequate newborn care and childbirth-related causes,“ said Ms. Cheryl Pinto, Director Glenmark. “Project Kavach of Glenmark Foundation addresses the core issue of high Infant and Child Mortality rates in the country and we hope to make a positive difference by implementing measures through successful partnerships with NGOs, Government and Local Communities,“ she added.
The launch of ‘Project Kavach’ in Rajasthan was preceded by the successful rollout of this child health campaign by Glenmark Foundation in Madhya Pradesh, India in the month of June, 2011.
About Glenmark Foundation
Instituted with the mission of ‘Enriching Lives‘; Glenmark Foundation is the Corporate Social Responsibility (CSR) arm of Glenmark. The Foundation has been implementing several projects for the benefit of the underprivileged sections of the society under 3 core areas:
- Sustainable Livelihoods
- Child Health
- Employee Volunteering
Glenmark Pharmaceuticals Ltd (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. It is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has eight molecules in various stages of clinical development and is primarily focused in the areas of Inflammation [asthma/COPD, rheumatoid arthritis, IBD, etc.] and Pain [neuropathic pain and inflammatory pain]. The company has a significant presence in branded generics markets across emerging economies including India. GPL along with its subsidiary has twelve manufacturing facilities in four countries and has five R&D centres.